5,7-Difluoro-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 1g

(2R)-2-{[(TERT-BUTOXY)CARBONYL]AMINO}-2-CYCLOHEPTYLACETIC ACID, 95.0%, 1g

6-(4-Methyl-piperazin-1-yl)pyridin-3-ylamine, 95.0%, 25g

Série ABT à échelle semi-micro Modèles calibrés en usine

8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one, 98%, 5g

(3-Benzyloxy-benzyl)-hydrazine hydrochloride, 97.0%, 250mg

3-Bromo-2-hydroxy-5-nitrobenzaldehyde, 95.0%, 100g

N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine, 98%, 5g

Tert-butyl 2-(piperidin-3-yl)acetate, 98%, 500mg

2-Chloro-4-methyl-7-aminoquinoline, 97.0%, 250mg

2-amino-5-(benzyloxy)-3,4-dihydropyrimidin-4-one, 95%, 250mg

(R)-(-)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetic acid, 96%, 1g

3-CHLORO-6-NITRO-1H-INDAZOLE, 97%, 1g